Dwight Moxie - 14 Sep 2022 Form 4 Insider Report for Revance Therapeutics, Inc.

Role
SVP, GC & Secretary
Signature
/s/ Dwight Moxie
Issuer symbol
N/A
Transactions as of
14 Sep 2022
Net transactions value
-$297,798
Form type
4
Filing time
16 Sep 2022, 16:55:56 UTC
Previous filing
17 Mar 2022
Next filing
09 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Sale $297,798 -11,000 -26% $27.07 31,694 14 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Moxie.
F2 This transaction was executed in multiple trades at prices ranging from $26.76 to $27.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.